RegeneRx Biopharmaceuticals, Inc. (RGRX)

RGRX Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Jan 21, 2025	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Market Capitalization	0	20	23	59	18	20
Market Cap Growth	-41.67%	-13.19%	-61.32%	222.53%	-7.52%	6.66%
Enterprise Value	16	21	23	60	18	20
Last Close Price	0.00	13.89	16.00	44.50	14.00	15.50
PS Ratio	0.03	259.75	299.21	773.59	239.84	285.75
PB Ratio	-4.03	-5.79	-10.30	-21.03	-7.87	-9.00
EV/Sales Ratio	208.22	271.61	293.91	784.13	237.60	280.80
Debt / Equity Ratio	-0.40	-0.42	-0.52	-0.36	-0.31	-0.02
Asset Turnover	0.13	0.09	0.08	0.12	0.15	0.27
Quick Ratio	0.06	0.53	2.86	1.07	2.64	0.75
Current Ratio	0.07	0.55	2.91	1.20	2.81	0.87
Return on Assets (ROA)	-148.50%	-105.12%	-90.41%	-128.07%	-158.88%	-325.56%
Earnings Yield	-79952.18%	-8.66%	-6.96%	-2.57%	-7.63%	-10.01%
FCF Yield	-5.47%	-4.72%	-4.31%	-1.70%	-6.18%	-4.46%
Buyback Yield / Dilution	-1.74%	-3.58%	-3.93%	-1.82%	-8.49%	0.18%
Total Shareholder Return	-1.74%	-3.58%	-3.93%	-1.82%	-8.49%	0.18%

Source: S&P Capital IQ. Standard template. Financial Sources.